310 related articles for article (PubMed ID: 37511115)
1. Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects.
Piergentili R; Gullo G; Basile G; Gulia C; Porrello A; Cucinella G; Marinelli E; Zaami S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511115
[TBL] [Abstract][Full Text] [Related]
2. Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?
Dellino M; Cerbone M; Laganà AS; Vitagliano A; Vimercati A; Marinaccio M; Baldini GM; Malvasi A; Cicinelli E; Damiani GR; Cazzato G; Cascardi E
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298731
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of pregnancy outcome after fertility-preserving treatment among women with atypical endometrial hyperplasia or endometrial carcinoma].
Xiao ZR; Lu Q; Zhou R; Wang YQ; Liang WY; Liu HX; Tang HR; Wu GZ; Liu XS; Zhang H; Ren Y; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):857-864. PubMed ID: 33355761
[No Abstract] [Full Text] [Related]
4. The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review.
Piatek S; Michalski W; Sobiczewski P; Bidzinski M; Szewczyk G
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():139-147. PubMed ID: 34214800
[TBL] [Abstract][Full Text] [Related]
5. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
[TBL] [Abstract][Full Text] [Related]
6. Fertility-preserving treatment and pregnancy outcomes in the early stage of endometrial carcinoma.
Tong XM; Lin XN; Jiang HF; Jiang LY; Zhang SY; Liang FB
Chin Med J (Engl); 2013; 126(15):2965-71. PubMed ID: 23924476
[TBL] [Abstract][Full Text] [Related]
7. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
[TBL] [Abstract][Full Text] [Related]
8. European Society of Gynecological Oncology Task Force for Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients.
Rodolakis A; Biliatis I; Morice P; Reed N; Mangler M; Kesic V; Denschlag D
Int J Gynecol Cancer; 2015 Sep; 25(7):1258-65. PubMed ID: 26186070
[TBL] [Abstract][Full Text] [Related]
9. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
Xi Y; Liu G; Liu D; Jiang J; Gong R
Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
[TBL] [Abstract][Full Text] [Related]
11. Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues.
Oliveira BL; Ataman LM; Rodrigues JK; Birchal TS; Reis FM
Reprod Biomed Online; 2021 Sep; 43(3):571-576. PubMed ID: 34332903
[TBL] [Abstract][Full Text] [Related]
12. Assisted Reproductive Technology Surveillance — United States, 2012.
Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
MMWR Surveill Summ; 2015 Aug; 64(6):1-29. PubMed ID: 26270152
[TBL] [Abstract][Full Text] [Related]
13. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.
Luke B; Brown MB; Wantman E; Schymura MJ; Browne ML; Fisher SC; Forestieri NE; Rao C; Nichols HB; Yazdy MM; Gershman ST; Sacha CR; Williams M; Ethen MK; Canfield MA; Doody KJ; Eisenberg ML; Baker VL; Williams C; Sutcliffe AG; Richard MA; Lupo PJ
Hum Reprod; 2022 Oct; 37(11):2672-2689. PubMed ID: 36112004
[TBL] [Abstract][Full Text] [Related]
14. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma.
Zhou L; Wang W; Wang F; Yang S; Hu J; Lu B; Pan Z; Ma Y; Zheng M; Zhou L; Lei S; Song P; Liu P; Lu W; Lu Y
Mol Cancer; 2021 Mar; 20(1):57. PubMed ID: 33781255
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients.
Zhou R; Yang Y; Lu Q; Wang J; Miao Y; Wang S; Wang Z; Zhao C; Wei L
Gynecol Oncol; 2015 Dec; 139(3):424-8. PubMed ID: 26428941
[TBL] [Abstract][Full Text] [Related]
16. Assisted Reproductive Technology Surveillance -
United States, 2013.
Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Warner L; Barfield WD;
MMWR Surveill Summ; 2015 Dec; 64(11):1-25. PubMed ID: 26633040
[TBL] [Abstract][Full Text] [Related]
17. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.
Ichinose M; Fujimoto A; Osuga Y; Minaguchi T; Kawana K; Yano T; Kozuma S
Int J Gynecol Cancer; 2013 Feb; 23(2):288-93. PubMed ID: 23314282
[TBL] [Abstract][Full Text] [Related]
18. Assisted reproductive technology surveillance -- United States, 2010.
Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].
Wang YQ; Zhou R; Xu LJ; Xia M; Lu Q; Liu GL; Shen DH; Wang G; He M; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):327-332. PubMed ID: 32464721
[No Abstract] [Full Text] [Related]
20. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
